InsightfulValue
← Back

Stock Swings

Price Drops

No drop incidents

Price Hikes

+11.54% closed: 2025-02-15

The solid gain came after the big biotech company announced its 2024 fourth-quarter and full-year financial results following market close on Tuesday. Gilead reported fourth-quarter revenue of $7.6 billion, up 6% year over year

+6.1% closed: 2024-11-10

Gilead Sciences’ stock price surge reflects a growing investor confidence in the company’s ability to deliver sustainable growth. The company’s strategic focus on therapeutic areas beyond its core offerings positions Gilead for continued success

Wait! There might be more — sign up or log in to see it

© 2024 InsightfulValue.com. All rights reserved. Legal